Figure 4B shows the results of the FSH receptor presence in the four ovarian tumor cell lines mostly studied, examined by the following differing detection techniques: immunoblot, ICC, RT-PCR, flow cytometry, cAMP assay, [125I]-FSH-binding radioreceptor assay and immunofluorescence. This evidence concerns the gene BRD2 and ovarian neoplasm.